QIAGEN OmicSoft and Biomedical Knowledge Base

Checkpoint inhibitors investigation in context of biomarkers, drug targets and pathways using Omicsoft and Ingenuity Pathway Analysis

132 views
September 15, 2022
This training will focus on how QIAGEN Omicsoft Studio and IPA can be used to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with user and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more.

In this training, you will learn how to:
· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases
· Derive a biomarker/gene signature from a specific condition (for example, non-responders of a drug, a specific disease/disease subtype and more)
· Correlate expression of multiple genes and biomarkers
· Compare different experimental groups (user and/or public data) at both gene expression and pathways/regulatory networks activity levels

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Exploring drug response in low-grade glioma

163 views August 31, 2022

See how Dr, Nilson from QIAGEN Digital Insights navigates an interesting...

QIAGEN OmicSoft and Biomedical Knowledge Base

Discoveries from public immuno-oncology studies using Omicsoft and Ingenuity Pathway Analysis

41 views January 12, 2023

This training will focus on how QIAGEN Omicsoft Studio and Ingenuity Pathway...

QIAGEN OmicSoft and Biomedical Knowledge Base

Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft

41 views December 01, 2022

In this 90-minute training, you’ll learn how to do drug treatment, toxicology...